Literature DB >> 23340039

Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease.

Claudio Babiloni1, Roberta Lizio, Claudio Del Percio, Nicola Marzano, Andrea Soricelli, Elena Salvatore, Raffaele Ferri, Filomena I I Cosentino, Gioacchino Tedeschi, Patrizia Montella, Silvia Marino, Simona De Salvo, Guido Rodriguez, Flavio Nobili, Fabrizio Vernieri, Francesca Ursini, Ciro Mundi, Jill C Richardson, Giovanni B Frisoni, Paolo M Rossini.   

Abstract

Cortical sources of resting state electroencephalographic (EEG) rhythms are abnormal in subjects with Alzheimer's disease (AD). Here we tested the hypothesis that these sources are also sensitive to the progression of early stage AD over the course of one year. The resting state eyes-closed EEG data were recorded in 88 mild AD patients at baseline (Mini Mental State Evaluation, MMSE I = 21.7 ± 0.2 standard error, SE) and at approximately one-year follow up (13.3 months ± 0.5 SE; MMSE II = 20 ± 0.4 SE). All patients received standard therapy with acetylcholinesterase inhibitors. EEG recordings were also performed in 35 normal elderly (Nold) subjects as controls. EEG rhythms of interest were delta (2-4 Hz), theta (4-8 Hz), alpha 1 (8-10.5 Hz), alpha 2 (10.5-13 Hz), beta 1 (13-20 Hz), beta 2 (20-30 Hz), and gamma (30-40 Hz). Cortical EEG sources were estimated by low-resolution brain electromagnetic tomography (LORETA). Compared to the Nold subjects, the mild AD patients were characterized by a power increase of widespread delta sources and by a power decrease of posterior alpha sources. In the mild AD patients, the follow-up EEG recordings showed increased power of widespread delta sources as well as decreased power of widespread alpha and posterior beta 1 sources. These results suggest that the resting state EEG sources were sensitive, at least at group level, to the cognitive decline occurring in the mild AD group over a one-year period, and might represent cost-effective and non-invasive markers with which to enrich cohorts of AD patients that decline faster for clinical studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340039     DOI: 10.3233/JAD-121750

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  15 in total

Review 1.  Aging, neurodegenerative disease, and traumatic brain injury: the role of neuroimaging.

Authors:  Carrie Esopenko; Brian Levine
Journal:  J Neurotrauma       Date:  2014-12-29       Impact factor: 5.269

2.  The predictive value of normal EEGs in dementia due to Alzheimer's disease.

Authors:  Casper T Briels; Cornelis J Stam; Philip Scheltens; Alida A Gouw
Journal:  Ann Clin Transl Neurol       Date:  2021-04-09       Impact factor: 4.511

Review 3.  Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel.

Authors:  Claudio Babiloni; Xianghong Arakaki; Hamed Azami; Karim Bennys; Katarzyna Blinowska; Laura Bonanni; Ana Bujan; Maria C Carrillo; Andrzej Cichocki; Jaisalmer de Frutos-Lucas; Claudio Del Percio; Bruno Dubois; Rebecca Edelmayer; Gary Egan; Stephane Epelbaum; Javier Escudero; Alan Evans; Francesca Farina; Keith Fargo; Alberto Fernández; Raffaele Ferri; Giovanni Frisoni; Harald Hampel; Michael G Harrington; Vesna Jelic; Jaeseung Jeong; Yang Jiang; Maciej Kaminski; Voyko Kavcic; Kerry Kilborn; Sanjeev Kumar; Alice Lam; Lew Lim; Roberta Lizio; David Lopez; Susanna Lopez; Brendan Lucey; Fernando Maestú; William J McGeown; Ian McKeith; Davide Vito Moretti; Flavio Nobili; Giuseppe Noce; John Olichney; Marco Onofrj; Ricardo Osorio; Mario Parra-Rodriguez; Tarek Rajji; Petra Ritter; Andrea Soricelli; Fabrizio Stocchi; Ioannis Tarnanas; John Paul Taylor; Stefan Teipel; Federico Tucci; Mitchell Valdes-Sosa; Pedro Valdes-Sosa; Marco Weiergräber; Gorsev Yener; Bahar Guntekin
Journal:  Alzheimers Dement       Date:  2021-04-15       Impact factor: 16.655

Review 4.  Electroencephalogram and Alzheimer's disease: clinical and research approaches.

Authors:  Anthoula Tsolaki; Dimitrios Kazis; Ioannis Kompatsiaris; Vasiliki Kosmidou; Magda Tsolaki
Journal:  Int J Alzheimers Dis       Date:  2014-04-24

5.  Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies.

Authors:  Laura Bonanni; Bernardo Perfetti; Stefania Bifolchetti; John-Paul Taylor; Raffaella Franciotti; Lucilla Parnetti; Astrid Thomas; Marco Onofrj
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

Review 6.  Amyloid-β: a potential link between epilepsy and cognitive decline.

Authors:  Michele Romoli; Arjune Sen; Lucilla Parnetti; Paolo Calabresi; Cinzia Costa
Journal:  Nat Rev Neurol       Date:  2021-06-11       Impact factor: 42.937

7.  Feasibility of Repeated Assessment of Cognitive Function in Older Adults Using a Wireless, Mobile, Dry-EEG Headset and Tablet-Based Games.

Authors:  Esther C McWilliams; Florentine M Barbey; John F Dyer; Md Nurul Islam; Bernadette McGuinness; Brian Murphy; Hugh Nolan; Peter Passmore; Laura M Rueda-Delgado; Alison R Buick
Journal:  Front Psychiatry       Date:  2021-06-25       Impact factor: 4.157

8.  Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer's disease.

Authors:  Davide V Moretti; Giovanni B Frisoni; Giuliano Binetti; Orazio Zanetti
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

9.  EEG Spectral Features Discriminate between Alzheimer's and Vascular Dementia.

Authors:  Emanuel Neto; Elena A Allen; Harald Aurlien; Helge Nordby; Tom Eichele
Journal:  Front Neurol       Date:  2015-02-13       Impact factor: 4.003

10.  Comparative analysis of the electroencephalogram in patients with Alzheimer's disease, diffuse axonal injury patients and healthy controls using LORETA analysis.

Authors:  Jéssica Natuline Ianof; Francisco José Fraga; Leonardo Alves Ferreira; Renato Teodoro Ramos; José Luiz Carlos Demario; Regina Baratho; Luís Fernando Hindi Basile; Ricardo Nitrini; Renato Anghinah
Journal:  Dement Neuropsychol       Date:  2017 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.